SynthesisNutrition journal2026
Dietary choline intake and incident dementia in middle-aged and older adults: a prospective cohort study and dose-response meta-analysis.
Synthesis in Nutrition journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCholine plays key roles in neurotransmitter synthesis and membrane integrity, processes fundamental to brain function. However, evidence from population studies on the association of dietary choline intake with dementia risk is mixed.
methodsWe analyzed data of 5,301 dementia-free participants (mean age = 68.6 years; 59% females) in the Health and Retirement Study and followed them through 2022. Dietary choline intake was assessed with a validated food frequency questionnaire (2013-2014) and energy-adjusted using the residual method. Incident dementia was identified with the Langa-Weir algorithm. Cox models estimated hazard ratios (HRs) across quintiles of total intake of choline and its contributing components. We additionally conducted a dose-response meta-analysis of existing prospective cohorts using a two-stage random-effects model with restricted cubic splines.
resultsDuring follow-up (median = 8.4 years, interquartile range: 6.4-8.9 years), 506 individuals developed dementia. Total choline intake showed a non-linear association with dementia risk. Compared with the lowest quintile, the multivariable-adjusted HRs (95% CI) for incident dementia across increasing quintiles of total choline were 0.88 (0.66-1.17), 0.87 (0.65-1.17), 0.68 (0.49-0.92), and 0.91 (0.66-1.25) (P-linear-trend: 0.198, P-non-linearity: 0.024). Among choline contributing components, moderate phosphatidylcholine and sphingomyelin intake levels were inversely associated with dementia risk (HR comparing quintile 4 to 1: 0.62, 95%CI: 0.46-0.84 and 0.70, 0.52-0.94, respectively). The meta-analysis of five cohorts (137,607 participants, 2459 dementia cases) showed an L-shaped association of dietary choline intake with dementia risk (P-linear-trend: 0.003, P-non-linearity: 0.036) with a turning point at 465 mg/day.
conclusionsIn this prospective cohort study and dose-response meta-analysis, moderate dietary choline intake was associated with a lower risk of incident dementia in middle-aged and older adults. These findings support further investigation of choline in relation to cognitive aging, particularly the potential non-linear association. REGISTRY FOR META-ANALYSES: CRD420251151642.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.